The Tisch Cancer Institute is currently seeking applicants for a full-time Clinical Trials Quality Assurance (QA) Manager. The QA Manager will be responsible for on-site data quality review and audits of all therapeutic clinical trials (Phase I, II, and III clinical studies) conducted at the Tisch Cancer Institute. Duties will include activities such as data management and system procedures, quality of data collection, training of new and existing staff, and protocol adherence.
The Tisch Cancer Institute is a vital component of the Icahn School of Medicine at Mount Sinai Hospital and plays a key role in the Mount Sinai Health System, which is one of the largest health care systems in the nation. We are a National Cancer Institute (NCI)-designated center and provide a multidisciplinary approach to cancer treatments and clinical breakthroughs that may one day put an end to cancer.
Our Cancer Clinical Trials Office (CCTO) provides the infrastructure and resources required to support patient-based cancer research. The CCTO is composed of regulatory, financial, clinical, study management, and data management personnel that support our disease management teams.
A Bachelor's of Science degree, or BSN in Nursing.
2-5 years’ experience managing clinical trials
In-depth understanding of GCP guidelines from ICH and NCI.
Demonstrated knowledge of clinical research concepts, and regulatory compliance
Internal Number: (req # 2421212)
About Mount Sinai School of Medicine
The Icahn School of Medicine at Mount Sinai is an international leader in medical and scientific training, biomedical research, and patient care. It is the medical school for the Mount Sinai Health System, which includes seven hospital campuses, and has more than 5,000 faculty and nearly 2,000 students, residents and fellows. Our unwavering pursuit of intellectual exchange, breakthrough research, and multidisciplinary teamwork propels us ever forward in biomedical discoveries and advances. We pursue ideas that often challenge conventional wisdom to revolutionize the practice of medicine and produce dramatically better outcomes for patients. We make big, bold bets by investing in radical free thinkers and technology at the cutting edge.